Pharmaniaga Bhd (XKLS:7081) GF Score: 46/100 (As of Aug. 07, 2026) — 19% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7081 Pharmaniaga Bhd XKLS:7081
46 GF Score
Price RM1.16
GF Value RM0.69
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd GF Score?

Pharmaniaga Bhd XKLS:7081 -0.85% 46 GF Score is 46 as of Aug. 07, 2026, which is 19% below its 10-year median of 57.00. GuruFocus rates XKLS:7081 with a GF Score™ of 46/100 and a GF Value™ of RM0.69 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Pharmaniaga Bhd has the GF Score of 46, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 3/10
2. Profitability Rank : 4/10
3. Growth Rank : 5/10
4. GF Value Rank : 1/10
5. Momentum Rank : 10/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Pharmaniaga Bhd might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Pharmaniaga Bhd  (XKLS:7081) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Pharmaniaga Bhd GF Score Related Terms

XKLS:7081 vs MCK, COR, CAH: GF Score Comparison

For the Medical Distribution subindustry, Pharmaniaga Bhd's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaniaga Bhd GF Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's GF Score distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's GF Score falls into.


XKLS:7081
46GF Score
Pharmaniaga Bhd XKLS:7081
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 46 mean?
Pharmaniaga Bhd (XKLS:7081) has a GF Score of 46 as of Aug. 07, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Pharmaniaga Bhd and its competitors. This is 19% below median its historical median of 57.00. Over the past decade, Pharmaniaga Bhd's GF Score has ranged from 32.00 to 74.00.
Is Pharmaniaga Bhd's GF Score too high?
Pharmaniaga Bhd's current GF Score of 46 is 19% below median its 10-year median of 57.00. Over the past 10 years, this metric has ranged from a low of 32.00 to a high of 74.00. Overall, Pharmaniaga Bhd has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's GF Score compare to MCK and COR?
Pharmaniaga Bhd's GF Score of 46 can be compared against companies in the Medical Distribution industry. Historically, Pharmaniaga Bhd's own GF Score has ranged from 32.00 to 74.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Pharmaniaga Bhd and its competitors. Pharmaniaga Bhd's current GF Score is 46, which is 19% below median its own 10-year median of 57.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.69, compared to a current price of RM1.16 — trading 68.1% above its estimated fair value. The current GF Score is 46, which is 19% below median its 10-year median of 57.00. Pharmaniaga Bhd's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current GF Score is 46 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.16 is trading 68.1% above its estimated GF Value™ of RM0.69. GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.

Key valuation signals for XKLS:7081:

  • GF Score: 46 (19% below median its 10-year median of 57.00)
  • GF Value™: RM0.69 vs. price of RM1.16 (68.1% above fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
46GF Score

Get the complete analysis for XKLS:7081

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.16
Price
RM0.69
GF Value